Comparison of Acute Effects of Myofascial Release and Kinesio Taping® in Dysmenorrhea

Not Applicable

Completed

• Conditions: Kinesio Taping; Myofascial Release Technique; Pain; Primary Dysmenorrhea (PD)

• Registration Number: NCT06925087
• Lead Sponsor: Cyprus International University

Brief Summary

Dysmenorrhea is a physiological condition and one of the most common issues experienced during menstruation. This study aims to compare the acute effects of Myofascial Release Technique (MRT) and Kinesio Taping® (KT) on pain severity, fatigue, and menstrual symptom severity in individuals with primary dysmenorrhea (PD).

Detailed Description

A total of 45 individuals diagnosed with PD will be randomly assigned to one of three groups: MRT, KT, or control. Pain severity and fatigue will be measured using the Visual Analog Scale (VAS), while menstrual symptom severity will be assessed with the Menstrual Symptom Scale, both prior to and following the interventions. The MRT group will be received MRT for three consecutive days starting from the onset of menstruation, whereas the KT group will be applied KT application for a duration of 72 hours. The control group did not receive any form of intervention.

Study Timeline

• Study Start: 2022-02-06
• Primary Completion: 2022-11-14
• Study Completion: 2025-02-20
• Status Verified: 2025-04
• Study First Submitted: 2025-04-06
• Study First Submitted QC: 2025-04-06
• Last Update Submitted: 2025-04-06
• Study First Posted: 2025-04-13
• Last Update Posted: 2025-04-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 45

Inclusion Criteria

• Daignosed with primary dysmenorrhea
• Regular menstruation in the past six months
• Experience menstrual pain ranging between 40-100 mm on the Visual Analog Scale

Exclusion Criteria

• Diagnosis of secondary dysmenorrhea
• A menstrual cycle length of less than 21 days or more than 35 days
• A history of childbirth or pregnancy
• Use of pharmacological treatments for menstrual pain
• A history of pelvic pathology or pelvic surgery
• The presence of neurological or systemic diseases

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Pain Severity	3 months	A 100 mm Visual Analog Scale (VAS), represented as a straight line with one end marked as 0 (no pain) and the other end as 10 (unbearable pain), will be used to measure pain severity. Participants will be asked to mark the point on the line that corresponded to the level of pain they will be experiencing during the evaluation. The marked point will be then measured using a ruler, and the numerical value of the pain severity will be recorded. Higher results indicate worse pain intensity.
Fatigue	3 months	A 100 mm Visual Analog Scale (VAS), with one end marked as 0 (no fatigue) and the other end as 10 (unbearable fatigue), will be used to evaluate the severity of fatigue experienced on the most intense day of menstruation. Participants will be asked to mark the point on the VAS that corresponded to the level of fatigue they will be felt. The marked point will then measured using a ruler, and the numerical value will be recorded. Higher results indicate worse pain intensity.
Menstrual Symptoms	3 months	The "Menstrual Symptom Scale," developed by Chesney and Tatso, will be used to evaluate the severity of menstrual symptoms. This scale consists of 22 items, each with five response options, and includes three subdimensions. The first 13 items belong to the "Negative Effects/Somatic Complaints" subdimension, items 14 to 19 fall under the "Menstrual Pain Symptoms" subdimension, and the last three items are part of the "Coping Methods" subdimension. The responses will be rated on a Likert-type scale ranging from 1 (never) to 5 (always). A higher total score indicates greater severity of menstrual symptoms.

Trial Locations

Locations (1)

Cyprus International University; 🇹🇷 Mersin, Lefkosa, Turkey